SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Clinical Trials
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Louis, T. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Louis, T. A
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Introduction

Introduction to Bayesian methods II: fundamental concepts

Thomas A Louis

Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, 615 North Wolfe Street, Baltimore, MD 21205, USA

The use of Bayesian design and analysis is burgeoning. In this introduction to Bayesian methods, we provide basic examples of Bayesian thinking and formalism on which more complicated and comprehensive approaches are built. These include adjusting estimates using related information, the use of Bayes theorem in diagnostic testing, the relationship of the prior and posterior distributions for situations where both the data and prior distribution are Gaussian, and the key steps in a Bayesian analysis. If Bayesian methods are carefully developed and applied, they have excellent objective (i.e., frequentist) properties, providing marvelous tools to help improve the FDA regulatory process.

Clinical Trials, Vol. 2, No. 4, 291-294 (2005)
DOI: 10.1191/1740774505cn099oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Clin TrialsHome page
S. Biswas, D. D Liu, J J. Lee, and D. A Berry
Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center
Clinical Trials, June 1, 2009; 6(3): 205 - 216.
[Abstract] [PDF]



Advertisement